Historical record - last NADAC effective date: 2/22/2017
Product Information
TRANDOLAPRIL 4 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2521 per EA under NDC 65862016601. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Jun 12, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862016601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
TRANDOLAPRILApproval Type
Generic (ANDA)
FDA Application
ANDA078438FDA Approved
6/12/2007
TE Code
AB
On Market Since
6/12/2007
Pharmacological Classes
Price Statistics
The NADAC for TRANDOLAPRIL 4 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2521 per EA |
|---|---|
| All-time high | $0.3443 (Jul 16, 2014) |
| All-time low | $0.1672 (Nov 23, 2016) |
| Median price | $0.2673 |
| Average price | $0.2662 |
| Largest weekly change | +58.8% (Dec 21, 2016) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-7.6%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trandolapril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRANDOLAPRIL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRANDOLAPRIL 4 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2521 per EA (NDC 65862016601), effective Feb 22, 2017.
How has the price of TRANDOLAPRIL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRANDOLAPRIL 4 MG TABLET has declined 7.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRANDOLAPRIL 4 MG TABLET?
Since Nov 28, 2013, the NADAC for TRANDOLAPRIL 4 MG TABLET has ranged from a low of $0.1672 (Nov 23, 2016) to a high of $0.3443 (Jul 16, 2014), with a median of $0.2673 per EA.
Are there cheaper alternatives to TRANDOLAPRIL 4 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRANDOLAPRIL 4 MG TABLET, is $0.1561 per EA — about 38% below TRANDOLAPRIL 4 MG TABLET.
Who manufactures TRANDOLAPRIL 4 MG TABLET?
TRANDOLAPRIL 4 MG TABLET (NDC 65862016601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.